HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Sells $10,446.30 in Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) major shareholder Of America Corp /De/ Bank sold 477 shares of HCA Healthcare stock in a transaction dated Tuesday, January 10th. The stock was sold at an average price of $21.90, for a total transaction of $10,446.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $342.25 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $84.26 billion, a price-to-earnings ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a fifty day moving average of $324.53 and a 200-day moving average of $340.92. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm posted $5.90 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. HCA Healthcare’s payout ratio is presently 13.11%.

Analysts Set New Price Targets

Several research firms recently commented on HCA. Barclays dropped their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Finally, KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

View Our Latest Stock Report on HCA

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $36,000. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare during the third quarter valued at about $39,000. Activest Wealth Management boosted its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.